Generic Hepatitis C Drugs as Effective as Pricey Brand Names: Study

SATURDAY, April 16, 2016 (HealthDay News) -- Low-cost generic antiviral drugs are as effective and safe as more expensive brand-name drugs in treating people with hepatitis C, researchers report. In many countries, people don't have access to a course of brand-name direct-acting antiviral drugs due to the high cost -- as much as $94,000 a patient, the researchers explained. However, mass-produced generic versions are available for less than 1 percent...